BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
AstraZeneca
Citi
Federal Trade Commission
Deloitte
Fuji
Colorcon
Merck
Argus Health

Generated: January 22, 2018

DrugPatentWatch Database Preview

NICOTROL Drug Profile

« Back to Dashboard

When do Nicotrol patents expire, and when can generic versions of Nicotrol launch?

Nicotrol is a drug marketed by Mcneil Cons, Pharmacia And Upjohn, and Pfizer Inc. and is included in three NDAs.

The generic ingredient in NICOTROL is nicotine. There are twenty-nine drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the nicotine profile page.
Drug patent expirations by year for NICOTROL
Pharmacology for NICOTROL
Ingredient-typeNicotine
Drug ClassCholinergic Nicotinic Agonist
Medical Subject Heading (MeSH) Categories for NICOTROL

US Patents and Regulatory Information for NICOTROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mcneil Cons NICOTROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020536-001 Jul 3, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn NICOTROL nicotine INHALANT;ORAL 020714-001 May 2, 1997 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer Inc NICOTROL nicotine SPRAY, METERED;NASAL 020385-001 Mar 22, 1996 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for NICOTROL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn NICOTROL nicotine INHALANT;ORAL 020714-001 May 2, 1997 ➤ Subscribe ➤ Subscribe
Mcneil Cons NICOTROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020536-001 Jul 3, 1996 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn NICOTROL nicotine INHALANT;ORAL 020714-001 May 2, 1997 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn NICOTROL nicotine INHALANT;ORAL 020714-001 May 2, 1997 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn NICOTROL nicotine INHALANT;ORAL 020714-001 May 2, 1997 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn NICOTROL nicotine INHALANT;ORAL 020714-001 May 2, 1997 ➤ Subscribe ➤ Subscribe
Mcneil Cons NICOTROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020536-001 Jul 3, 1996 ➤ Subscribe ➤ Subscribe
Mcneil Cons NICOTROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020536-001 Jul 3, 1996 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn NICOTROL nicotine INHALANT;ORAL 020714-001 May 2, 1997 ➤ Subscribe ➤ Subscribe
Pfizer Inc NICOTROL nicotine SPRAY, METERED;NASAL 020385-001 Mar 22, 1996 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Daiichi Sankyo
Federal Trade Commission
Express Scripts
Citi
Covington
Farmers Insurance
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot